Loading
Every dated change on the records linked to Mesothelioma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
CT and PET/CT; thoracoscopic biopsy with IHC panel (calretinin, WT1, D2-40; BAP1 and MTAP loss support malignancy); histology and BAP1/MTAP status recorded for treatment planning. (NCCN MPM guideline)
Stopped early; primary endpoint not met.
A milestone in how this cancer is treated.
OS not significantly improved overall; benefit in non-epithelioid subgroup.
OS HR 1.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
OS 18.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
PFS HR 1.
Median OS 18.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
Unresectable pleural mesothelioma with cisplatin
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.